CDKN2A and Barrett esophagus: Interestingly, BAR-T cells, derived from BE with constitutive loss of CDKN2A, increase cell doubling times upon TP53 knockdown46, supporting the hypothesis that the additional loss of TP53 reduces cell growth rate.